Dual angiogenesis and PD-1 blockade in hepatocellular carcinoma

Julien Calderaro^{1

2}

Affiliations

¹ Département de Pathologie, Centre Hospitalier Universitaire Henri Mondor, Assistance Publique Hôpitaux de Paris, Créteil, France.
² Inserm U955, Team 18, Université Paris-Est Créteil, Créteil, France.

Editorial

Julien Calderaro. Hepatobiliary Surg Nutr. 2020 Jun.

. 2020 Jun;9(3):350-352.

doi: 10.21037/hbsn.2019.10.37.

Julien Calderaro^{1

2}

¹ Département de Pathologie, Centre Hospitalier Universitaire Henri Mondor, Assistance Publique Hôpitaux de Paris, Créteil, France.
² Inserm U955, Team 18, Université Paris-Est Créteil, Créteil, France.

No abstract available

Conflict of interest statement

Conflicts of Interest: The author has no conflicts of interest to declare.

Dual Programmed Death Receptor-1 and Vascular Endothelial Growth Factor Receptor-2 Blockade Promotes Vascular Normalization and Enhances Antitumor Immune Responses in Hepatocellular Carcinoma.
Shigeta K, Datta M, Hato T, Kitahara S, Chen IX, Matsui A, Kikuchi H, Mamessier E, Aoki S, Ramjiawan RR, Ochiai H, Bardeesy N, Huang P, Cobbold M, Zhu AX, Jain RK, Duda DG. Shigeta K, et al. Hepatology. 2020 Apr;71(4):1247-1261. doi: 10.1002/hep.30889. Epub 2019 Oct 14. Hepatology. 2020. PMID: 31378984 Free PMC article.

1. Villanueva A. Hepatocellular Carcinoma. N Engl J Med 2019;380:1450-62. 10.1056/NEJMra1713263 - DOI - PubMed
1. Zhu AX, Kang YK, Yen CJ, et al. Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased alpha-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol 2019;20:282-96. 10.1016/S1470-2045(18)30937-9 - DOI - PubMed
1. Ziol M, Poté N, Amaddeo G, et al. Macrotrabecular-massive hepatocellular carcinoma: A distinctive histological subtype with clinical relevance. Hepatology 2018;68:103-12. 10.1002/hep.29762 - DOI - PubMed
1. Calderaro J, Ziol M, Paradis V, et al. Molecular and histological correlations in liver cancer. J Hepatol 2019;71:616-30. 10.1016/j.jhep.2019.06.001 - DOI - PubMed
1. Calderaro J, Meunier L, Nguyen CT, et al. ESM1 as a marker of macrotrabecular-massive hepatocellular carcinoma. Clin Cancer Res 2019;25:5859-65. 10.1158/1078-0432.CCR-19-0859 - DOI - PubMed